Heptelidic acid , CAS No.57710-57-3

CAS: 57710-57-3 Cat. No.: H646838 Formula: C15H20O5 Peso molecolare: 280.32
Disponibile su ordine
Synonyms
Avocettin | SCHEMBL20199901 | (5aS,6R,9S,9aS)-1-oxo-6-propan-2-ylspiro[3,5a,6,7,8,9a-hexahydro-2-benzoxepine-9,2'-oxirane]-4-carboxylic acid | DTXSID901105608 | (5aS,6R,9S,9aS)-1-Oxo-6-(propan-2-yl)-3,5a,6,7,8,9a-hexahydro-1H-spiro[2-benzoxepine-9,2'-oxir
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
★
Dimensione
Germania (EU)
USA*
Prezzo
Qtà
1mg
H646838-1mg
Su ordinazione · 8–12 settimane
1.805,68€
Enter a quantity for the sizes you want to add.
🧪
Perché questa qualità

per flussi di lavoro cromatografici e analitici sensibili che richiedono un'interferenza minima della linea di base.

🌡

Stoccaggio e spedizione

Store at -20°C Spedizione Ice chest + Ice pads. Consultare il COA specifico del lotto per le specifiche esatte.

📋

Documenti di qualità

SDS, COA, scheda tecnica e scheda delle specifiche disponibili per il download. COA specifico del lotto accessibile tramite ricerca per numero di lotto.

📚

Prova documentale

Citato in 0 pubblicazioni peer-reviewed su cromatografia, sintesi organica e reazioni di accoppiamento incrociato.

Panoramica

Heptelidic acid (Koningic acid) is a sesquiterpene antibiotic. Heptelidic acid inhibits Etoposide-induced apoptosis via downregulation of caspases . Koningic acid (KA) is a specific GAPDH inhibitor with an IC 50 of 90 μM .

In Vitro

Heptelidic acid is a sesquiterpene antibiotic, found in the culture filtrate of three different strains of fungi isolated from soil samples. Heptelidic acid produces organisms, fermentation, isolation and characterization. Heptelidic acid inhibits Etoposide-induced apoptosis in human leukemia U937 cells.Heptelidic acid inhibits caspase- 3 induction in U937 cells with an IC 50 value of 40 μM after 8 h of Etoposide treatment. Heptelidic acid (Koningic acid; KA), a natural product obtained from the Trichoderma fungus, can directly bind to the active site of human GAPDH. The expression of T. koningii KAr-GAPDH successfully rescued cell viability in human cells treated with Heptelidic acid. HEK293T cells expressing T. koningii KAr-GAPDH exhibited complete cell viability after treatment with 0-200 μM Heptelidic acid with the IC 50 =5 μM. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Cell Viability AssayCell Line: HEK293T cells expressing KAr-GAPDH or EV (top left) Concentration: 0.1, 1, 10, 100, 1000 μM Incubation Time: 24 hours Result: IC 50 =5 μM.

In Vivo

Heptelidic acid (Koningic acid; KA) is bioavailable and induces dynamic changes to glycolysis in vivo. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: 6-week old female Foxn1 nu mice bearing BT-474 tumorDosage: 1, 2.5, 5, and 10 mg/kg Administration: Daily intraperitoneal (IP) injections, 24 hours Result: 1 mg/kg was determined to be the maximum tolerated dose (MTD) based upon behavioral monitoring and adverse events at higher doses (hemolysis, hematuria, and anemia).

Form:Solid

Specifiche

Sinonimi
Avocettin | SCHEMBL20199901 | (5aS,6R,9S,9aS)-1-oxo-6-propan-2-ylspiro[3,5a,6,7,8,9a-hexahydro-2-benzoxepine-9,2'-oxirane]-4-carboxylic acid | DTXSID901105608 | (5aS,6R,9S,9aS)-1-Oxo-6-(propan-2-yl)-3,5a,6,7,8,9a-hexahydro-1H-spiro[2-benzoxepine-9,2'-oxir
Meccanismi biochimici e fisiologici
Heptelidic acid (Koningic acid) is a sesquiterpene antibiotic. Heptelidic acid inhibits Etoposide-induced apoptosis via downregulation of caspases. Koningic acid (KA) is a specific GAPDH inhibitor with an IC 50 of 90 μM .
Condizioni di conservazione di stoccaggio
Store at -20°C
Spedito in
Ice chest + Ice pads
Questo prodotto richiede spedizione a catena fredda. I servizi di terra e altri servizi economici non sono disponibili.
Tipo di azione
INHIBITOR
Nomi e identificatori
Sorrisi canonici
CC(C)C1CCC2(CO2)C3C1C=C(COC3=O)C(=O)O
IUPAC Name
(5aS,6R,9S,9aS)-1-oxo-6-propan-2-ylspiro[3,5a,6,7,8,9a-hexahydro-2-benzoxepine-9,2'-oxirane]-4-carboxylic acid
InChIKey
JESMSCGUTIEROV-RTWAVKEYSA-N
INCHI
1S/C15H20O5/c1-8(2)10-3-4-15(7-20-15)12-11(10)5-9(13(16)17)6-19-14(12)18/h5,8,10-12H,3-4,6-7H2,1-2H3,(H,16,17)/t10-,11-,12-,15-/m1/s1
Isomeri SMILES
CC(C)[C@H]1CC[C@@]2(CO2)[C@@H]3[C@@H]1C=C(COC3=O)C(=O)O
Peso molecolare
280.32
Reaxy-Rn
30085085
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=30085085&ln=

Documentazione

📋 Scheda di dati di sicurezza (SDS)

Documento completo su pericoli, manipolazione, stoccaggio e conformità normativa.

<<<<<<< HEAD Scarica SDS → ======= Scarica SDS → >>>>>>> release248-p3

✅ Certificato di analisi (COA)

Dati di qualità specifici del lotto. Inserisci il numero di lotto per recuperare il COA esatto.

Cerca COA →

📊 Scheda tecnica

Riepilogo di riferimento rapido delle specifiche e applicazioni del prodotto.

Visualizza scheda tecnica →

🔬 Scheda delle specifiche

Attributi di qualità completi e criteri di accettazione per questa qualità.

Visualizza scheda delle specifiche →

Dati avanzati

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassLipids and lipid-like molecules
ClassePrenol lipids
SubclassTerpene lactones
Intermediate Tree Nodes Not available
Direct ParentTerpene lactones
Alternative Parents Sesquiterpenoids  Dicarboxylic acids and derivatives  Lactones  Carboxylic acid esters  Oxacyclic compounds  Epoxides  Dialkyl ethers  Carboxylic acids  Organic oxides  Hydrocarbon derivatives  Carbonyl compounds  
Molecular FrameworkAliphatic heteropolycyclic compounds
Substituents Terpene lactone - Sesquiterpenoid - Dicarboxylic acid or derivatives - Carboxylic acid ester - Lactone - Carboxylic acid derivative - Carboxylic acid - Dialkyl ether - Oxirane - Ether - Oxacycle - Organoheterocyclic compound - Organic oxygen compound - Carbonyl group - Hydrocarbon derivative - Organooxygen compound - Organic oxide - Aliphatic heteropolycyclic compound
DescrizioneThis compound belongs to the class of organic compounds known as terpene lactones. These are prenol lipids containing a lactone ring.
External Descriptors Not available
Struttura 3D
Modello di struttura chimica interattiva





Obiettivi associati (umani)
A-375 (9258 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DU-145 (51482 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HL-60 (67320 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KM12 (47707 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OVCAR-3 (48710 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PANC-1 (6144 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-OV-3 (52876 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TK-10 (45540 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
T47D (39041 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HEK293 (82097 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H460 (60772 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HOP-62 (47048 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Obiettivi associati (non umani)
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PC-12 (7051 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Meccanismi d'azione
Certificati (CoA, COO, BSE/TSE e tabella di analisi)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Proprietà chimiche e fisiche
Peso molecolare280.320 g/mol
XLogP31.400
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count5
Rotatable Bond Count2
Exact Mass280.131 Da
Monoisotopic Mass280.131 Da
Topological Polar Surface Area76.100 Ų
Heavy Atom Count20
Formal Charge0
Complexity481.000
Isotope Atom Count0
Defined Atom Stereocenter Count4
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds0
Covalently-Bonded Unit Count1
Calcolatori di soluzioni
Recensioni

Recensioni dei clienti

Application Protocols

Item-specific, tested protocols and recommended dilutions are not provided in the Product Data.

General research-use guidance (non-validated, literature-informed):

  • Stock preparation: dissolve in anhydrous DMSO to prepare a concentrated stock. Filter if sterility is required (PTFE/PVDF). Record exact concentration by gravimetry or quantitative NMR if needed.
  • Working solutions: dilute into assay buffer immediately before use; maintain low organic cosolvent (e.g., ≤1–2% v/v DMSO) unless your assay tolerates more.
  • Controls: include vehicle controls, time-course controls, and, where relevant, inactive analogs or thiol scavengers to probe covalency.
  • Storage of working solutions: avoid long storage in aqueous media; prepare fresh to preserve epoxide/lactone integrity.

For detailed, validated protocols (e.g., WB, IHC, IF, FC), please refer to primary literature or develop in-house SOPs.

Biological Roles

Literature-based overview (for research context; not a medical claim):

  • Origin: Heptelidic acid (koningic acid) is a fungal polyketide metabolite.
  • Primary biochemical activity: potent, irreversible inhibition of glyceraldehyde-3-phosphate dehydrogenase (GAPDH), attributed to covalent modification via its epoxide. This disrupts glycolytic flux in cell-free and cellular models and is used to interrogate glycolysis-dependent phenotypes.
  • Selectivity considerations: literature reports relative selectivity for GAPDH among glycolytic enzymes, though off-target alkylation of other nucleophilic proteins can occur at higher concentrations or prolonged exposure due to the inherent reactivity of epoxides.
  • Cellular consequences (research observations): altered NAD+/NADH balance, accumulation of upstream glycolytic intermediates, and metabolic reprogramming. These effects are context dependent and should be validated in the relevant system.
  • Probe development: the scaffold has been derivatized to attach reporter tags (e.g., biotin/fluorophores) for activity-based protein profiling, leveraging the electrophilic center while retaining binding determinants.

Best practices:

  • Use appropriate controls (inactive analogs, rescue experiments with substrate or thiol scavengers) to confirm on-target GAPDH engagement.
  • Validate concentration–response relationships and exposure times to balance potency with potential non-specific reactivity.
Buffer Applications

Not typically used as a buffering agent. As an acidic small-molecule tool compound, heptelidic acid is introduced into existing biological buffers for assays rather than serving as the buffer itself.

Practical notes (general):

  • Prepare concentrated stock solutions in DMSO and dilute into assay buffer immediately before use.
  • Avoid high-pH buffers (≥8.5–9) or nucleophile-rich media for extended periods to minimize epoxide/lactone degradation.
  • If increased aqueous solubility is required, limited titration with base can form the carboxylate, but monitor for decomposition and revert to neutral pH promptly.
Green Alternatives

Scope: This section addresses greener choices for solvents and workflow when handling heptelidic acid; the compound itself is a specific natural product and not typically replaced in studies probing its unique mode of action.

Greener solvent choices (general guidance):

  • Preferable diluents for stock preparation: water with minimal DMSO cosolvent where feasible. If organic solvent is needed, ethanol is generally considered more benign than DMF/DMF-like solvents.
  • For chromatography: shift from chlorinated eluents to alcohol/water or acetonitrile/water systems on reversed-phase columns. Use buffered aqueous mobile phases at near-neutral pH to limit degradation.

Comparison (general sustainability view):

  • DMSO vs DMF: DMSO has a better EHS profile and lower volatility; choose DMSO over DMF for stocks when compatible.
  • Ethanol vs acetonitrile: ethanol is greener but can broaden peaks; acetonitrile offers performance but has higher environmental burden.

Process considerations:

  • Minimize solvent volumes by using concentrated DMSO stocks and immediate dilution into assay buffers.
  • Reduce waste by adopting microscale assay formats (384/1536-well plates) and inline analytical methods.

Note: There is no direct “green substitute” for heptelidic acid’s biochemical role; consider alternative GAPDH modulators only if aligned with your study design and safety objectives.

Pharmaceutical Uses

No item-specific pharmacopeial status or excipient role is provided for this product.

General context (non-clinical, for research and manufacturing insights only):

  • Heptelidic acid is primarily a research tool compound and natural product standard. It is not commonly employed as a pharmaceutical excipient.
  • Potential roles in R&D workflows include: reference standard for analytical method development (e.g., LC–MS), positive control for target engagement assays, and starting point for medicinal chemistry exploration of covalent modulators.
  • Regulatory considerations: if used in regulated environments (e.g., GLP analytical labs), ensure traceability via CoA, validated analytical methods, and documented storage conditions.

Statement of use: For research use only (per Product Data). Not for human or veterinary use.

Physical Properties

Item-specific specifications:

  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular Formula: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular Weight: Not specified for this item; refer to CoA/Spec Sheet.

Literature and general reference values (for context only; not item specifications):

  • Molecular formula (literature): C16H22O7
  • Molecular weight (literature): ~326.34 g/mol
  • Acidic functionality: contains a carboxylic acid (expected to be deprotonated at basic pH; pKa for similar polyoxygenated carboxylic acids often ~3–5, literature generalization)
  • Polarity/solubility (typical):
    • Soluble in polar aprotic organic solvents (e.g., DMSO) and alcohols; limited aqueous solubility at neutral pH due to hydrophobic scaffold; increased solubility in basic aqueous media via carboxylate formation.
    • Hygroscopic tendencies are not widely reported; handle under dry conditions to protect epoxide and lactone moieties.
  • LogP: Not readily available in standard references; expect moderate polarity due to multiple oxygens (literature expectation).
  • MP/BP/Refractive index/Density: Not specified for this item; consult primary literature or CoA.

Practical notes:

  • The epoxide and lactone functionalities are sensitive to strong acid/base and nucleophiles; prolonged exposure to high pH or nucleophilic buffers may induce ring opening or hydrolysis (literature behavior of epoxylactones).
Quality and Grades

Item-specific:

  • Grade/Purity: Not specified for this item; refer to CoA/Spec Sheet.

Guidance on interpreting grades (general):

  • Research/Biochemical grade typically emphasizes structural identity and purity appropriate for mechanistic enzymology or chemical biology screens. When purity is specified (e.g., ≥95% HPLC), it reflects the main component area by HPLC/UPLC with controlled residual solvents/metals.
  • For small-molecule tool compounds like heptelidic acid, low-level stereochemical or oxidative impurities can impact activity. Review chromatograms and NMR where available.
  • UV-Vis background and residual water/peroxides are generally not specified for non-solvent reagents; if your application is sensitive (e.g., enzyme kinetics), request full analytical data (1H/13C NMR, HRMS, HPLC purity, water by Karl Fischer) from the CoA.

Stabilizer/additives:

  • None specified for this item. If stabilizers or salts are used, they should be declared on the CoA; absence typically indicates the free acid form.

Fit-for-purpose recommendations:

  • For quantitative biochemical assays, verify: stereochemical integrity (chiroptical or chiral HPLC), absence of hydrolysis products (lactone/epoxide opening), and confirm counterion content (free acid vs. salt).
Reaction and Applications

Context: Heptelidic acid is primarily used as a biochemical tool compound rather than as a reagent or solvent. Its notable reactivity derives from its epoxide and lactone functionalities.

Research applications (literature):

  • Enzyme mechanistic studies: widely used as a covalent, irreversible probe of glycolytic glyceraldehyde-3-phosphate dehydrogenase (GAPDH), reacting with active-site nucleophiles (e.g., Cys) via epoxide opening.
  • Chemical biology: applied in target engagement assays, activity-based profiling, and pathway perturbation studies in carbohydrate metabolism. It can serve as a positive control for GAPDH inhibition in cell-free systems.
  • Natural products and biosynthesis: reference standard for polyketide biosynthetic investigations and stereochemical assignment protocols.

Chemical reactivity considerations (general):

  • Epoxide: susceptible to nucleophilic ring opening (thiols, amines, alkoxides). Rate and regioselectivity are solvent and pH dependent.
  • Lactone: vulnerable to hydrolysis under base or acid, producing hydroxyacids; transesterification possible in alcohols with acid/base catalysis.
  • Carboxylic acid: enables salt formation (for solubility) and coupling chemistry (amide/ester formation) if derivatization is desired for probe development.

Practical tips:

  • Maintain neutral to slightly acidic conditions during handling to preserve the epoxide/lactone.
  • For biochemical testing, prepare fresh dilutions and minimize exposure to high pH or nucleophile-rich buffers to retain activity.
Reaction Conditions

Item-specific, validated reaction conditions are not provided for this product.

General guidance drawn from literature chemistry of epoxylactone natural products:

  • Stability window: neutral, anhydrous organic solvents at ambient temperature; avoid extended exposure to pH >8 or strong acids.
  • Epoxide opening: proceeds with soft nucleophiles (e.g., thiols, amines) in polar protic or aprotic solvents (MeOH, EtOH, DMF, DMSO) at 0–25°C; catalysts (Lewis acids/bases) modulate regioselectivity. Reaction times: minutes to hours depending on nucleophile strength.
  • Esterification/Amidation (carboxylic acid): typical peptide-coupling conditions (EDCI or HATU, base such as DIPEA) in DMF/DCM at 0–25°C, 0.5–12 h. Monitor carefully to avoid unintended epoxide opening; add coupling reagents at low temperature.
  • Lactone hydrolysis: aqueous THF/MeOH with mild base (e.g., NaHCO3) at 0–25°C yields hydroxyacid; stronger base (NaOH) accelerates but risks epoxide loss.

Analytical monitoring:

  • LC–MS (ESI negative) and 1H NMR are preferred for tracking integrity of the epoxide/lactone.

Note: Conditions above are general literature practices for related scaffolds and should be re-optimized for heptelidic acid; perform small-scale trials and confirm structure by NMR/MS.

Safety and Handling

Item-specific hazard information:

  • Signal Word: Not specified for this item; refer to SDS.
  • H-Statements: Not specified for this item; refer to SDS.
  • GHS Classification/Pictograms: Not specified for this item; refer to SDS.

General safety guidance (literature/precautionary, not a substitute for SDS):

  • Likely hazards: organic acids with epoxide/lactone motifs can be irritating to skin/eyes and harmful if swallowed; epoxides are generally reactive toward biological nucleophiles.
  • PPE: lab coat, nitrile gloves, safety glasses or splash goggles; work in a chemical fume hood to avoid inhalation of dust/aerosols.
  • Handling: minimize exposure to strong bases/acids and nucleophiles which can trigger decomposition; avoid heat and prolonged light.
  • Incompatibilities: strong bases (epoxide/lactone opening), strong acids (hydrolysis), strong nucleophiles (e.g., amines, thiols), reducing agents targeting epoxides, and oxidants that may over-oxidize polyols.
  • First aid (overview):
    • Skin/eye contact: rinse with plenty of water for at least 15 minutes; remove contaminated clothing; seek medical attention if irritation persists.
    • Inhalation: move to fresh air; seek medical attention if symptoms occur.
    • Ingestion: rinse mouth; do not induce vomiting; obtain medical advice.

Storage and shipping (item-specific):

  • Storage Conditions: Store at -20°C (per Product Data). Keep container tightly closed, desiccated, and protected from light.
  • Shipped In: Ice chest + Ice pads (per Product Data).

Always consult the SDS for authoritative hazard classifications and response measures.

Solvent Selection

Applicability: Heptelidic acid is a polyoxygenated small molecule (carboxylic acid, lactone, epoxide, alcohols). It is not a bulk solvent; this section addresses solvents suitable for dissolving/handling it.

General solvent behavior (literature-informed):

  • Preferred stock-solution solvents: DMSO (typical for screening libraries), DMF, and alcohols (MeOH, EtOH). These balance polarity and stability.
  • Aqueous media: Limited solubility at neutral pH; solubility improves in basic buffers by forming the carboxylate, but strong base increases risk of epoxide/lactone opening. If aqueous delivery is needed, prepare a concentrated DMSO stock and dilute into buffer immediately before use (maintain final DMSO ≤1–2% v/v for biochemical assays as needed).
  • Nonpolar solvents (EtOAc, dichloromethane, toluene): variable solubility; EtOAc often acceptable. Chlorinated solvents and strong nucleophilic solvents may accelerate decomposition if warmed.

Selection tips:

  • For bioassays: DMSO stocks (e.g., 10–50 mM) are common; filter-sterilize if required using PTFE or PVDF membranes.
  • For purification/analytical work: MeOH/H2O or ACN/H2O (0.1% acid modifier) systems often give sharp HPLC peaks for polyoxygenated natural products; avoid high-pH eluents.

Quick comparison (general):

  • DMSO: highest solvating power; best for stable freezer stocks.
  • MeOH/EtOH: good solvency; easier evaporation; can participate in transesterification at high pH/temperature.
  • Aqueous basic buffers: increase solubility but risk functional group degradation; use minimally and briefly.
Storage and Reconstitution

Item-specific conditions (from Product Data):

  • Storage: Store at -20°C.
  • Shipping: Ice chest + Ice pads.

General best practices (supplemental, not item specifications):

  • Container: store in airtight, light-protective vials with desiccant. If supplied as a solid, equilibrate to room temperature before opening to prevent condensation.
  • Stability: avoid repeated freeze–thaw and prolonged exposure to moisture, base, or strong nucleophiles to protect epoxide and lactone.
  • Reconstitution: prepare concentrated stock solutions in anhydrous DMSO. If aqueous formulations are required, dilute immediately before use into neutral buffers; minimize time at elevated pH.
  • Aliquoting: prepare single-use aliquots to reduce freeze–thaw cycles. Clearly label concentration, solvent, and date of preparation.
  • Working concentration range: Not specified for this item; determine empirically for your assay.

Always consult the product’s CoA/Spec Sheet for any additional, lot-specific handling or stability information.

Structure and Identity

Item-specific (from Product Data):

  • CAS: 57710-57-3
  • PubChem CID: 10945834
  • InChIKey: 158472 (as listed; note this is not in standard 27-character format)
  • SMILES: Not specified for this item; refer to CoA/Spec Sheet.

Literature identity (general reference information):

  • Synonyms: Heptelidic acid; Koningic acid (fungal polyketide metabolite)
  • Molecular formula: C16H22O7 (literature)
  • Molecular weight: ~326.34 g/mol (literature)
  • Core structural motifs (literature description): bicyclic framework featuring a γ-lactone fused to a tetrahydrofuran-like ring, with an electrophilic epoxide and multiple hydroxyl substituents; one free carboxylic acid. Multiple stereogenic centers define its absolute configuration.
  • Functional groups (literature): carboxylic acid, lactone (cyclic ester), epoxide, secondary/tertiary alcohols; densely oxygenated polyketide architecture.

2D structure (verbal description, literature): a compact, oxygen-rich bicyclic system; an epoxide ring is embedded adjacent to the lactone carbonyl, with hydroxyl groups arrayed around the fused ring system and a pendant carboxylate-bearing side chain. Stereochemistry is fixed at several contiguous chiral centers.

Notes:

  • When definitive identifiers (SMILES/InChI) are required, consult authoritative databases (e.g., PubChem CID 10945834) or the product CoA to avoid stereochemical ambiguity.
Synthetic Utility

Perspective: Heptelidic acid is more often the target of synthesis than a reagent. Nevertheless, its functional groups offer derivatization opportunities for probe and SAR development.

Functional-group reactivity (general):

  • Carboxylic acid: amenable to amidation/esterification (e.g., EDCI/HOBt, HATU, or Steglich conditions) to install handles (alkynes, azides, biotin) for conjugation.
  • Epoxide: can be opened regioselectively by soft nucleophiles (e.g., thiols) under mild conditions to generate adducts; however, such modifications typically abolish GAPDH inhibition.
  • Lactone: under controlled conditions, hydrolysis affords hydroxyacid derivatives; re-lactonization may be feasible for analog synthesis.
  • Alcohols: selective protection (e.g., silyl ethers, acylation) enables stepwise modification without compromising the core.

Applications:

  • Synthesis of activity-based probes: introduce reporter tags via the acid functionality while preserving the electrophilic epoxide.
  • Isotopic labeling: incorporation of 13C/2H-labeled fragments through late-stage coupling for metabolic tracing or quantitative LC–MS.

Cautions:

  • Multicenter stereochemistry necessitates protecting-group strategies and mild conditions to avoid epimerization or undesired ring opening.
  • Maintain near-neutral conditions when possible to preserve the native epoxide/lactone during manipulations.
Target Specificity

Item-specific target and validation data are not provided in the Product Data for this catalog entry.

General note:

  • While literature discusses heptelidic acid as a covalent inhibitor of GAPDH, Aladdin Scientific provides this compound for research use without a guaranteed target profile. Users should perform their own target engagement and selectivity assays suitable for their system.

Domande frequenti

How should this product be stored?
Store at ?20 °C. Freezer storage is required to maintain the specified shelf life.
How is this product shipped?
This product ships in an insulated container with ice pads. Unpack on arrival and transfer it to the storage condition stated above.
What are the CAS number, molecular formula and molecular weight?
The CAS Number is 57710-57-3, the molecular formula is C15H20O5, and the molecular weight is 280.32 g/mol. InChIKey JESMSCGUTIEROV-RTWAVKEYSA-N.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.

Desidera che le inviamo un messaggio quando avremo sconti disponibili?

Ricordamelo più tardi

Grazie! Controlli la sua casella di posta per confermare.

Ops! Le notifiche sono disabilitate.